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The plant cytotoxin ricin enters target mammalian cells by recep-
tor-mediated endocytosis and undergoes retrograde transport to
the endoplasmic reticulum (ER). Here, its catalytic A chain (RTA) is
reductively separated from the cell-binding B chain, and free RTA
enters the cytosol where it inactivates ribosomes. Cytosolic entry
requires unfolding of RTA and dislocation across the ER membrane
such that it arrives in the cytosol in a vulnerable, nonnative
conformation. Clearly, for such a dislocated toxin to become active,
it must avoid degradation and fold to a catalytic conformation.
Here, we show that, in vitro, Hsc70 prevents aggregation of
heat-treated RTA, and that RTA catalytic activity is recovered after
chaperone treatment. A combination of pharmacological inhibition
and cochaperone expression reveals that, in vivo, cytosolic RTA is
scrutinized sequentially by the Hsc70 and Hsp90 cytosolic chaper-
one machineries, and that its eventual fate is determined by the
balance of activities of cochaperones that regulate Hsc70 and
Hsp90 functions. Cytotoxic activity follows Hsc70-mediated escape
of RTA from an otherwise destructive pathway facilitated by
Hsp90. We demonstrate a role for cytosolic chaperones, proteins
typically associated with folding nascent proteins, assembling
multimolecular protein complexes and degrading cytosolic and
stalled, cotranslocational clients, in a toxin triage, in which both
toxin folding and degradation are initiated from chaperone-bound
states.
Hsc70  Hsp90  ricin
Endoplasmic-reticulum (ER) associated protein degradation(ERAD) comprises coordinated disposal systems that rec-
ognize and remove misfolded and unassembled proteins in the
ER, dislocating them across the ER membrane to the cytosol for
proteasomal destruction. Degradation is normally facilitated by
polyubiquitylation, usually on internal lysyl residues of the target
protein. Both membrane-bound and soluble ER proteins can be
disposed of by ERAD (1, 2).
The plant cytotoxin ricin traffics to the ER lumen of mam-
malian cells where it is reduced to its RTA and RTB subunits
before RTA dislocation (3). RTA does not penetrate the ER
membrane directly; instead it exploits pre-existing protein-
conducting channels as a nonnative species, mimicking ER
proteins dispatched via ERAD (4, 5). Thus, it enters the cytosol
in a form susceptible to proteolysis or aggregation. A proportion
must evade these fates to gain a catalytic conformation that
depurinates target ribosomes, stopping protein synthesis. The
paucity of lysine residues in RTAmay facilitate uncoupling from
ERAD by reducing the potential for polyubiquitylation, thereby
hampering proteasomal degradation (6). This, in turn, may
provide opportunities for spontaneous or chaperone-assisted
folding not normally sanctioned for ERAD substrates.
We show an interaction of RTA with the cytosolic heat shock
(cognate) protein Hsc70. From the chaperone-bound state,
nonnative cytosolic RTA can achieve a catalytic conformation or
can be inactivated. Its ultimate fate depends on the activities of
cochaperones that regulate Hsc70.
Results
Inhibition of Hsc70 Protects HeLa Cells from Ricin. Ricin binds
exposed galactosyl residues, opportunistically exploiting a huge
number of surface glycoproteins (3). Consequently, trafficking
pathways are diverse with 5% of the cell-surface bound toxin
reaching the TGN (7). Of this, only a tiny proportion reaches the
ER (8) and subsequently the cytosol. RTA is not modified in
transit, so the toxic cytosolic fraction cannot be distinguished
from the overwhelming noncytotoxic majority at the cell surface
and in the endomembrane system by immunoblotting, cellular
fractionation, indirect immunofluorescence, or coimmunopre-
cipitation approaches. However, ricin cytotoxicity correlates
strongly with ribosome depurination, so it can be used as a
measure of the relative amount of native RTA in the cytosol (9).
Deoxyspergualin (DSG) alters the ATPase activity of the
cytosolic heat-shock (cognate) protein Hsc70 in vitro, and in vivo
permits expression of functional cystic fibrosis transmembrane
conductance regulator (CFTR) in cells expressing mutant
F508CFTR, presumably by inhibiting interactions with Hsc70
chaperone complexes that target it to proteasomes (10, 11).
When DSG was added with ricin to HeLa cells, the cells became
3-fold more resistant to toxin (Fig. 1 A and B), suggesting that
an increased proportion of toxin remained inactive. DSG alone
had no effect on protein synthesis (Fig. 1C). The ER Hsp70
counterpart BiP is not affected by DSG (12), suggesting that
protection occurred in the cytosol. After ricin challenge, a
distinct lag before the onset of cytotoxicity that represents
trafficking time from cell surface to the first destruction of
ribosomes (13) is unchanged by DSG treatment (Table 1),
confirming that the effect of DSG occurs in the cytosol, and not
by interfering with toxin delivery. Because unfolding is necessary
to render RTA competent for dislocation (5), then folding must
be required for catalytic activity in the cytosol, and this appears
to involve Hsc70. In contrast, DSG had no effect on the potency
of diphtheria toxin (DTx, Fig. 1 A and B), which enters the
cytosol from acidified endosomes, refolding spontaneously in
the cytosol (14).
Inhibition of Hsp90 Sensitizes Cells to Ricin.DSG also interacts with
the cytosolic chaperone Hsp90 (10). To clarify its most upstream
target, we used geldanamycin (GA) and radicicol (RA), com-
petitive inhibitors of the Hsp90 ATP-binding site (15). Treat-
ment with 1 M GA or RA resulted in a 1.5- to 2-fold
sensitization of cells to ricin (Fig. 2 A and B), without altering
toxin trafficking times (Table 1). Treatments with GA or RA
alone have little, if any, effect on protein synthesis (Fig. 2C).
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Prolonged inhibition of Hsp90 by GA up-regulates Hsp72 (16).
We saw the same, confirming activity of GA and RA under our
conditions (Fig. 2D). Our sensitizing effects were obtained by
using acute drug treatments, before up-regulation of Hsp72, but
even with a 4-h drug pretreatment, cells were still sensitized to
ricin (data not shown). Thus, the effects of GA and RA do not
arise through augmented levels of Hsp72. GA and RA also
interact with GRP94, the ER counterpart of Hsp90. NECA
(N-ethylcarboxamidoadenosine), a GRP94 inhibitor that does
not affect Hsp90 (17) protected cells slightly from ricin (1.48 
0.34 -fold, n  5), confirming that the sensitizing effects of GA
and RA arose from inhibition of cytosolic Hsp90 and not GRP94
(Fig. 2B). It also suggests a role for GRP94 in preparing RTA for
dislocation, consistent with its ability to direct the null Hong
Kong variant of 1-antitrypsin to ERAD (18).
These data suggest that the fate of RTA is determined by
cytosolic triage, with an activation arm (toxin-sensitizing) inhib-
ited by DSG and an inactivation arm (protective) inhibited by
GA and RA. Combined treatment with DSG and RA gave a net
protective effect against ricin (Fig. 2B), demonstrating a sequen-
tial process with the step promoted by Hsc70 lying upstream of
the step mediated by Hsp90.
Hsc70 Interacts with RTA in Vitro. Because the minuscule amounts
of cytosolic RTA preclude detection except by monitoring the
consequences of its catalytic action, interactions with Hsp70 and
its cochaperone Hsp40 were examined in vitro. Brief heating to
45°C destabilizes RTA structure (19). RTA became insoluble (P,
pellet) after such treatment (15 min), with 10% remaining
soluble (S) after centrifugation (Fig. 3A, upper panel, upper
graph). Incremental increases in recovery of soluble material
were obtained by adding Hsp40, Hsp70, or both before heating.
Maximal chaperone-mediated solubility required ATP. These
data suggest that a potential role for these chaperones in vivo
could be to prevent vulnerable dislocated RTA from aggregat-
ing. Hsp40 was insoluble after heat treatment, alleviated by
addition of Hsc70. Repeating these assays in the absence of RTA
showed that this is its normal behavior (Fig. 3A, middle panel).
Fig. 1. Deoxyspergualin (DSG) protects HeLa cells from ricin intoxication. (A) Cells were treated for 4 h with graded doses of ricin or diphtheria toxin (DTx) in
growth medium containing 50 g ml1 DSG/100 g ml1 lactose (filled circles) or 100 g ml1 lactose carrier only (open circles), and their subsequent ability to
synthesize proteins was determined by measuring incorporation of [35S]-Met into acid-precipitable material. Typical single assays are shown. (B) Control cells and
cells pretreated (pre) with DSG/lactose were treated as in A, sensitivities to toxin (IC50, toxin concentration required to reduce protein synthesis to 50% that of
nontoxin treated controls) were determined, and fold protection (IC50 DSG-treated cells: IC50 control cells) is displayed. Means of three (DTx, ricin 16-h DSG
pretreatment) or six (ricin, no DSG pretreatment) independent experiments are displayed. (Bars,1 S.D.; broken line, no protective effect over that of treatment
with lactose carrier only). (C) Cells were treated with lactose (lac) or lactose/DSG only as appropriate for 4 h, and remaining protein synthesis ability was
determined. (n  3; bars, 1 S.D.).
Table 1. Ricin cell-surface to cytosol trafficking times
Treatment T, min
100 g ml1 lactose carrier 62.4  1.2
50 g ml1 DSG/ lactose 64.7  1.8
0.001% DMSO vehicle 68.0  6.3
1 M geldanamycin/DMSO 63.4  9.8
1 M radicicol/DMSO 65.2  8.3
T, n  3–6,  1 SD.
Fig. 2. Geldanamycin (GA) and radicicol (RA) sensitize HeLa cells to ricin
challenge. (A) Cells were treated (4 h) with increasing doses of ricin in medium
containing GA/DMSO (black circles), RA/DMSO (gray circles), or DMSO vehicle
only (white circles), and their subsequent ability to synthesize proteins was
determined as in Fig. 1A. Typical single assays are shown. (B) Cells were
challenged as in (A), IC50 values were determined as in Fig. 1B, and the effects
of GA and RA are displayed as fold sensitizations (IC50 GA- or RA-treated cells:
IC50 control DMSO-treated cells). Also shown are the effects of treatment with
NECA, and combined treatments with RA, DSG, and DMSO. Means of three
independent experiments are displayed, except for NECA treatment, where
n 5. (Bars,1 S.D.; broken line, no effect over that of treatment with DMSO
vehicle only) (C) Cells were treated with vehicle DMSO, DMSO/GA, or
DMSO/RA as appropriate for 4 h, and remaining protein synthesis ability was
determined. (n  3; bars, 1 S.D.) (D) Immunoblots of detergent soluble cell
extracts (25 g protein per lane) from cells incubated for various lengths of
time (t) in growth medium containing 1 M GA or 1 M RA were probed for
Hsp72 (upper strip), Hsp90 (middle strip), or -tubulin (lower strip).








When RTA was heated for 15 min with or without chaperones
at 37°C, the chaperones had a similar although less pronounced
effect (Fig. 3A, lower panel, lower graph). Saporin has a largely
indistinguishable tertiary structure relative to RTA with iden-
tical, superimposable active site residues and has identical
activity against ribosomes (20), but it lacks the C-terminal
hydrophobic stretch that in RTA has been implicated in mem-
brane interactions preceding dislocation (21). Saporin showed
no thermal instability (Fig. 3B) after heating at 45°C. This result
contrasts with the instability of RTA and its recognition by
Hsp40/Hsc70 even at 37°C, and suggests that interactions with
Hsc70 might be a normal feature of folded RTA in the cytosol.
To investigate whether chaperone-treated RTA had cata-
lytic activity, dilutions of the soluble fractions from heat-
treated RTA and chaperone-stabilized RTA were added to
yeast ribosomes, which were subsequently treated with acidi-
fied aniline. Correctly folded RTA specifically depurinates
yeast 26S rRNA, and aniline treatment cleaves the phosphodi-
ester bond at the depurination site, releasing a small diagnostic
fragment of RNA (22). As expected, a small amount of RTA
activity remained after heat-treatment, but almost full activity
was recovered from chaperone-stabilized RTA (Fig. 3C). We
conclude that the major proportion of denatured RTA with
chaperone-mediated solubility is, or can become, competent to
gain catalytic activity.
Hsc70 Cochaperone Activity Determines the Fate of Dislocated RTA in
Vivo. Having established that RTA interacts with Hsc70 in vitro
and that catalytic activity can be recovered from the chaperone-
bound state, we examined the effects of modulating Hsc70
cochaperone activities in vivo.
The dual cochaperone Hsc70-Hsp90 organizing protein (Hop)
recruits Hsp90 to pre-existing Hsc70-client complexes, transfer-
ring client proteins from Hsc70 to Hsp90 (23). Transient over-
expression of Hop protected cells from ricin challenge (Fig. 4 A
and C), suggesting that increased links between Hsc70 and
Hsp90 lead to increased toxin turnover, consistent with the
sensitizing effects of GA/RA that block entry into the Hsp90
cycle. Thus, sequential interaction with Hsc70 and Hsp90 directs
cytosolic RTA toward net inactivation.
BCL2-associated athanogene protein (BAG-1) isoforms are
nucleotide exchange factors that stimulate release of Hsc70-
bound clients and bear a ubiquitin-like (ubl) motif that interacts
with the proteasome (24). Transient overexpression of BAG-1
protected cells against ricin (Fig. 4 B and D). Thus, BAG-1 may
stimulate release of Hsc70-bound RTA on a path toward inac-
tivation, consistent with the increased sensitivity of cells to ricin
reported after inhibition of proteasome activity (25).
Both Hsc70- and Hsp90- complexes can become sorting
machines that promote client destruction. C terminus of Hsp70-
interacting protein (CHIP) is an E3 ubiquitin ligase that interacts
with Hsc70 and Hsp90, and with its partner ubiquitin-
conjugating enzymes initiates proteasomal sorting by ubiquity-
lating chaperone-bound substrates. Transient over-expression of
CHIP resulted in enhanced inactivation of RTA, seen as in-
creased resistance of cells to ricin (Fig. 4 B and E).
To investigate whether Hsc70 can also promote toxin activity
in vivo, we overexpressed Hsp70-interacting protein (Hip), a
Hsc70 cochaperone, which stabilizes ADP-bound Hsc70, in-
Fig. 3. In vitro interactions of RTA and Hsp40 and Hsc70 chaperones. (A) RTA (500 ng) was incubated at the indicated temperatures for 15 min in 20 l of 20
mM Mops pH 7.2, 100 mM KCl, in the presence or absence of Hsp40, Hsc70, or ATP (shown below the panels). Aggregated (P) and soluble (S) fractions were
separated by centrifugation, heated in reducing SDS sample buffer, and analyzed by SDS/PAGE and subsequent silver staining. *, proteolytic fragment of Hsc70
lacking the C-terminal regulatory domain. Proportions (%) of aggregated (gray) and soluble (white) RTA are shown. (Bars,1 S.D.) (B) Reaction mixtures where
RTA was replaced by saporin were treated as in (A). (C) Dilutions of the soluble fractions from 375 ng of heat-treated RTA (upper panel), 375 ng of
chaperone-stabilized RTA (lower panel), and 375 ng of native RTA were added to yeast ribosomes for 2 h at 30°C. After cleavage of any depurinated 28S rRNA
with acetic-aniline, rRNAs were extracted, electrophoresed in denaturing conditions (1.2% agarose, 50% formamide), and gels were stained with ethidium
bromide before quantifying (22).
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creasing client residence and presumably permitting greater
opportunity for productive folding (26). Over-expression of
Hip-sensitized cells to ricin challenge (Fig. 4 B and F); thus, Hip
controls an activation arm of RTA triage.
The BAG-2 nucleotide exchange factor lacks the ubl domain
of BAG-1 and thus, cannot link a client:chaperone complex
directly to the proteasome. It also inhibits CHIP activity (27).
These properties allow it to facilitate maturation of newly
synthesized CFTR, diverting the receptor from the proteasome
pathway (28). Consistent with this, BAG-2 overexpression in-
creased the sensitivity of cells to ricin (Fig. 4 B and G),
demonstrating diversion of RTA from a destructive fate. We
conclude that the ultimate fate of cytosolic RTA is determined
by the relative expression levels of Hsc70 cochaperones.
RTA Can Be a Substrate for CHIP.Our inhibitor and expression data
demonstrate that activation and inactivation arms for RTA
proceed from Hsc70, and suggest that inactivation may require
a ubiquitin signal, either indirectly [via the interlaced ubl domain
of BAG-1 or perhaps in a piggy-back mechanism through Hsc70
ubiquitylation (29)], or directly (as CHIP-mediated RTA ubiq-
uitylation). To examine the latter, purified RTA was added to
reaction mixtures in which CHIP activity can be recapitulated in
vitro (30), which were then incubated for 2 h at 30°C. In complete
reaction mixtures and also when E1 (ubiquitin activating en-
zyme), E2 (ubiquitin conjugating enzyme), CHIP, or Hsp40/
Hsc70 were individually absent from the reconstitutions, no
ubiquitylation of RTA was seen (data not shown). However,
after mild thermal denaturation (45°C, 10 min) followed by
incubation at 30°C in complete reaction mixture not only was
Hsc70 ubiquitylated (Fig. 5A, Ub-Hsc70, upper panel) but so was
a small proportion of RTA (Fig. 5A, Ub-RTA, lower panel). An
even smaller proportion of RTA was a substrate for isolated
CHIP.
The scrutiny of native RTA at 37°C by Hsc70 complexes that
was noted previously (Fig. 3A) was also seen with Hsc70/CHIP
complexes. After incubation at 37°C for 2 h in the absence of E1,
there was no ubiquitylation of Hsc70, CHIP, or RTA (Fig. 5B).
Upon addition of E1, both Hsc70 and CHIP became ubiquity-
lated, events that occur in vivo that reflect regulation of Hsc70
by CHIP (28). Not all proteins are ubiquitylated in these
conditions, for example, BAG-2 inhibits CHIP activity without
becoming ubiquitylated (28). A recombinant version of RTA
containing four extra lysyl residues (RTA 6K) was more heavily
ubiquitylated under these conditions, consistent with its en-
hanced propensity for proteasomal degradation (25). A small
proportion of native wild-type RTA (2K) was also a substrate for
the Hsc70/CHIP cochaperone machinery (Fig. 5B).
Hsp90 also prevented aggregation of heat-treated RTA in
vitro, but in an ATP-independent manner (Fig. 5C, upper panel
and graph), but, unlike Hsc70, had no effect at 37°C (Fig. 5C,
lower panel and graph). Furthermore, in in vitro CHIP-mediated
ubiquitylation assays at 37°C, Hsp90 alone could not direct CHIP
efficiently toward RTA, but in the presence of Hsc70 and HOP,
Hsp90 promoted RTA ubiquitylation, thus providing a rationale
for the net protective effect of Hsp90 in vivo (Fig. 5D). We
conclude that both nonnative and native RTA at the physiolog-
ical temperature for ricin intoxication can be substrates for
Hsc70- and Hsp90-CHIP complexes, and that sequential Hsc70-
Hsp90 interactions lead to net RTA inactivation.
Discussion
Molecular chaperones are widely regarded as cellular protein
folding factors governing folding of nascent and damaged pro-
tein clients, and as protein assembly factors. During ER trans-
location, yeast cytosolic chaperones target ER import-
incompetent proteins to the proteasome (31). In mammalian
cells, roles for Hsc70 have been demonstrated in CFTR triage
(32) and in cotranslocational destruction of apoB that has stalled
in the import translocon (33). Here, we demonstrate that a
luminal protein that exploits the ERAD pathway for dislocation
is also scrutinized by the same machineries. Prevailing concen-
trations of Hsc70 cochaperones determine the proportion of
toxin that can recover catalytic activity and the proportion that
is destroyed. The simplest model to account for our findings is
shown in Fig. 5E, illustrating chaperone-mediated triage of
cytosolic RTA. After dislocation, RTA is recognized by the
Hsc70 chaperone machinery. Cochaperones BAG-2 and Hip
promote RTA activity in vivo, resulting in increased sensitivity of
cells to ricin. Inactivation arms also proceed from Hsc70,
controlled by BAG-1 and CHIP, protecting the cell from ricin
toxicity. In addition, the dual cochaperone Hop coordinates a
sequential Hsc70-Hsp90 triage whose net effect is to render
dislocated RTA inactive. Inactivation may be mediated by
ubiquitylation machineries. Both gain of catalytic conformation
and degradation of RTA proceed from chaperone-bound states.
This is highly reminiscent of the Hsc70-Hsp90 mediated regu-
lation of signaling proteins (34), but may be unprecedented for
a soluble protein that is dislocated from the ER lumen, because
soluble ERAD substrates typically interact with other mem-
brane-associated chaperone machineries (35), whereas cytosolic
domains of misfolded membrane proteins typically interact with
Hsc70 complexes (36). Our findings emphasize the central role
of Hsc70-Hsp90 chaperone machineries in cytosolic protein
triage. A minimal role for Hsc70 appears to be to prevent
aggregation of dislocated RTA in the cytosol, but the possibility
Fig. 4. Hsc70 cochaperone activity determines the fate of dislocated RTA in
vivo. (A) Cells transiently transfected with an expression plasmid expressing
Hop (Hop/Hop), with an equimolar mixture of plasmids expressing LacZ and
Hop (Hop/LacZ), or with a plasmid expressing LacZ (LacZ/LacZ) were assayed
for ricin sensitivity. Values were corrected for transfection efficiency, deter-
mined as 35% by epifluorescent examination of cells transiently transfected
with a plasmid expressing GFP. Dotted line, no effect over that of LacZ
transfection. (B) Cells were transfected, as in (A), with expression plasmids
expressing LacZ, BAG-1S [the small (S) isomer of BAG-1], CHIP, Hip, or BAG-2
and were assayed for ricin sensitivity compared with cells transfected coevally
with vector alone. Dotted line, no protective effect over vector transfection.
(C–G) Interactions of cochaperones with Hsc70 and client protein (red line).








of Hsc70 supporting the folding of RTA directly cannot yet be
discounted.
Folding of heat-denatured RTA in vitro is favored in the
presence of ribosomes, implicating the toxin’s substrate in its
own activation (19). It remains to be seen whether human
homologues of ribosome-tethered chaperones that assist folding
of nascent proteins (37, 38) also contribute to posttranslational
folding of cytosolic RTA and how significant a role they have
relative to the soluble chaperone complexes.
Materials and Methods
Cytotoxicity Measurements. HeLa cell responses to 4-h challenges with graded
doses of ricin or diphtheria toxin (DTx) were measured as previously described
(3). For pharmacological studies, cells were treated coevally with graded doses
of toxin in medium containing carrier or solvent vehicle (control) and with
toxin dilutions in medium containing both carrier/vehicle and pharmacolog-
ical agent. Each cytotoxicity curve was normalized to controls not treated with
toxin, but containing agent or vehicle as appropriate, so any effects of agent
alone on protein synthesis were accounted for. Toxin trafficking times from
cell surface to first destruction of ribosomes were measured as previously
described (13). DSG was supplied by Worldwide Clinical Development, Nippon
Kayaku Co., Ltd., 31–12, Shimo 3-chome, Kita-ku, Tokyo 115-0042, Japan.
Overexpression Studies. HeLa cells were transfected with vectors expressing
cochaperones, using previously published conditions (3). Two days posttrans-
fection, cells were seeded into 96-well plates and grown overnight for cyto-
toxicity studies. Overexpression of cochaperones was confirmed by using
FLAG-tagged versions of these proteins, and immunoblotting using an anti-
FLAG antibody (data not shown).
In Vitro Ubiquitylation, Aggregation, and RTA Activity Studies. Recombinant
RTA was added to reaction mixtures containing 0.1M E1 ubiquitin activating
enzyme, 0.3 M Hsp40, 3 M Hsc70, 3 M HOP, 3 M Hsp90, 4 M UbcH5 (E2
conjugating enzyme), 3M CHIP, and 2 mg.ml1 ubiquitin in 20 mM Mops, pH
7.2, 100 mM KCl, 5 mM MgCl2, 5 mM ATP, 10 mM DTT buffer as previously
described (28) and to reaction mixtures lacking components as appropriate.
After incubation (2 h) at 30°C or 37°C as appropriate, products were identified
by reducing SDS/PAGE and immunoblot. When required, reaction mixes lack-
ing ATP and MgCl2 were heated to 45°C for 10 min followed by cooling to the
required reaction temperature and activation of the reaction by addition of
ATP and MgCl2. For aggregation studies, reaction mixtures lacking E1, E2,
CHIP, and Ub were used, and RTA was heated to 37°C or 45°C in the presence
or absence of Hsp40, Hsc70, Hsp90, and ATP. Aggregated and soluble fractions
were separated by centrifugation (16,000g, 10 min), solubilized in reducing
SDS sample buffer, and analyzed by SDS/PAGE and silver staining. Catalytic
activity of RTA from soluble fractions was assayed by quantifiying the RNA
Fig. 5. RTA is a substrate for CHIP. (A) RTA was added to a reaction mixture (complete), which can recapitulate CHIP activity (28), and to mixtures lacking E1
ubiquitin activating enzyme, E2 (UbcH5 ubiquitin conjugating enzyme), CHIP, or Hsp40/Hsc70 (40/70) as indicated. After heating (45°C, 10 min), reactions were
activated by addition of 5 mM MgCl2, 10 mM DTT, and 5 mM ATP, incubated (2h, 30°C), and products were identified by reducing SDS/PAGE and immunoblotting
for Hsc70 and RTA. (B) Addition of E1 to a reaction mixture containing RTA, Hsp40, Hsc70, E2, CHIP, and ubiquitin as in A, and incubation at 37°C for 2 h results
in CHIP-mediated ubiquitylation of Hsc70 (upper panel, Ub-Hsc70), CHIP (middle panel, Ub-CHIP), and both RTA 6K and RTA (lower panel, Ub-RTA) as revealed
by immunoblots. (C) RTA (500 ng) was incubated (45°C or 37°C, 15 min) in the presence or absence of Hsp90 or ATP (shown below the panels). Aggregated (P)
and soluble (S) fractions were separated by centrifugation, heated in reducing SDS sample buffer, and analyzed by SDS/PAGE and subsequent silver staining.
Proportions (%) of aggregated (gray) and soluble (white) RTA are shown. (D) RTA was added to CHIP recapitulation mixtures as in A, but containing Hsp40 and
Hsp70 (40/70), HOP, and Hsp90 as indicated below the panels, incubated (2 h, 37°C), and products were identified by reducing SDS/PAGE and immunoblotting
for HOP and RTA, and by silver staining for Hsc70 and Hsp90. *, cross-reacting contaminant. (E) Proposed cytosolic triage of dislocated RTA.
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fragment released from yeast 26S rRNA after RTA-mediated depurination of
intact ribosomes and cleavage with acetic-aniline. rRNA species were resolved
by denaturing gel electrophoresis, and fragments quantified in relation to the
amount of 5.8S rRNA (22). Bands on silver-stained and ethidium bromide
stained gels were quantified by using TotalLab software.
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